{
    "Trade/Device Name(s)": [
        "RapidFRET Oral Fluid Assay for Cocaine",
        "RapidFRET Oral Fluid Cocaine Calibrator Set",
        "RapidFRET Oral Fluid Cocaine Control Set"
    ],
    "Submitter Information": "Biophor Diagnostics, Inc.",
    "510(k) Number": "K142129",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101742"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DLJ",
        "DIF"
    ],
    "Summary Letter Date": "July 1, 2015",
    "Summary Letter Received Date": "July 6, 2015",
    "Submission Date": "July 23, 2015",
    "Regulation Number(s)": [
        "21CFR862.3250",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system",
        "Clinical toxicology calibrator",
        "Drug mixture control materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Cocaine",
        "Benzoylecgonine",
        "Cocaethylene",
        "Norcocaine",
        "Ecgonine",
        "Ecgonine methyl ester",
        "Cinnamoylcocaine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [
        "RapidEASE Oral Fluid Collector",
        "Glass sample tube with inert screw cap"
    ],
    "Instrument(s)/Platform(s)": [
        "RapidFRET Integrated Workstation"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive homogeneous immunoassay",
        "Time-resolved fluorescence",
        "Fluorescence resonance energy transfer (FRET)"
    ],
    "Methodologies": [
        "Immunoassay",
        "FRET",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for RapidFRET Oral Fluid Assay for Cocaine, Calibrator and Control Set, a FRET-based immunoassay for oral fluid cocaine screening in central laboratories",
    "Indications for Use Summary": "Qualitative screen for cocaine at 20 ng/mL in neat oral fluid samples collected with the RapidEASE Oral Fluid Collector, for prescription use in central laboratories only on the RapidFRET Integrated Workstation; provides preliminary results, requiring confirmation by GC/MS or LC/MS/MS.",
    "fda_folder": "Toxicology"
}